| Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study M Kocher, R Soffietti, U Abacioglu, S Villa, F Fauchon, BG Baumert, ... Journal of Clinical Oncology 29 (2), 134-141, 2011 | 2172 | 2011 |
| Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. P Romestaing, Y Lehingue, C Carrie, R Coquard, X Montbarbon, ... Journal of clinical oncology 15 (3), 963-968, 1997 | 901 | 1997 |
| A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain … R Soffietti, M Kocher, UM Abacioglu, S Villa, F Fauchon, BG Baumert, ... Journal of clinical oncology 31 (1), 65-72, 2013 | 707 | 2013 |
| Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial CA Meyers, JA Smith, A Bezjak, MP Mehta, J Liebmann, T Illidge, ... Journal of clinical oncology 22 (1), 157-165, 2004 | 686 | 2004 |
| Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease C Fermé, H Eghbali, JH Meerwaldt, C Rieux, J Bosq, F Berger, T Girinsky, ... New England Journal of Medicine 357 (19), 1916-1927, 2007 | 568 | 2007 |
| Phase III Randomized Trial of Calendula Officinalis Compared With Trolamine for the Prevention of Acute Dermatitis During Irradiation for Breast Cancer P Pommier, F Gomez, MP Sunyach, A D'hombres, C Carrie, ... Journal of clinical oncology 22 (8), 1447-1453, 2004 | 565 | 2004 |
| Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01 P Pommier, S Chabaud, JL Lagrange, P Richaud, F Lesaunier, E Le Prise, ... Journal of Clinical Oncology 25 (34), 5366-5373, 2007 | 410 | 2007 |
| Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised … C Carrie, A Hasbini, G de Laroche, P Richaud, S Guerif, I Latorzeff, ... The Lancet Oncology 17 (6), 747-756, 2016 | 404 | 2016 |
| Involved-field radiotherapy for advanced Hodgkin's lymphoma BMP Aleman, JMM Raemaekers, U Tirelli, R Bortolus, MB van't Veer, ... New England Journal of Medicine 348 (24), 2396-2406, 2003 | 401 | 2003 |
| Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial B Lannering, S Rutkowski, F Doz, B Pizer, G Gustafsson, A Navajas, ... Journal of clinical oncology 30 (26), 3187-3193, 2012 | 375 | 2012 |
| A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis L Claude, D Pérol, C Ginestet, L Falchero, D Arpin, M Vincent, I Martel, ... Radiotherapy and oncology 71 (2), 175-181, 2004 | 308 | 2004 |
| Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy C Hennequin, N Bossard, S Servagi-Vernat, P Maingon, JB Dubois, ... International Journal of Radiation Oncology* Biology* Physics 86 (5), 860-866, 2013 | 297 | 2013 |
| Short androgen suppression and radiation dose escalation for intermediate-and high-risk localized prostate cancer: results of EORTC trial 22991 M Bolla, P Maingon, C Carrie, S Villa, P Kitsios, PMP Poortmans, ... Journal of clinical oncology 34 (15), 1748-1756, 2016 | 231 | 2016 |
| Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study) O Oberlin, MC Le Deley, BNG Bui, JC Gentet, T Philip, P Terrier, C Carrie, ... British journal of cancer 85 (11), 1646-1654, 2001 | 206 | 2001 |
| Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of … C Carrie, N Magné, P Burban-Provost, P Sargos, I Latorzeff, JL Lagrange, ... The Lancet Oncology 20 (12), 1740-1749, 2019 | 202 | 2019 |
| Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis D Arpin, D Perol, JY Blay, L Falchero, L Claude, S Vuillermoz-Blas, ... Journal of clinical oncology 23 (34), 8748-8756, 2005 | 199 | 2005 |
| Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients C Carrie, C Lasset, C Alapetite, JP Maire, C Haie‐Meder, S Hoffstetter, ... Cancer 74 (8), 2352-2360, 1994 | 189 | 1994 |
| Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP) C Carrie, S Hoffstetter, F Gomez, V Moncho, F Doz, C Alapetite, ... International Journal of Radiation Oncology* Biology* Physics 45 (2), 435-439, 1999 | 181 | 1999 |
| Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study V Oyharcabal-Bourden, C Kalifa, JC Gentet, D Frappaz, C Edan, ... Journal of clinical oncology 23 (21), 4726-4734, 2005 | 177 | 2005 |
| Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non–small-cell lung cancer patients with brain metastases: results … MP Mehta, WR Shapiro, SC Phan, R Gervais, C Carrie, P Chabot, ... International Journal of Radiation Oncology* Biology* Physics 73 (4), 1069-1076, 2009 | 175 | 2009 |
